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Abstract
To determine the involvement of Ca2+ sensitization in β-adrenergic action, we
examined  the  relationship  between  isometric  tension  and  intracellular  Ca2+
concentration  (F340/F380)  in  the  inhibitory  action  of  isoproterenol  (ISO)  against
methacholine (MCh)- induced contraction, using fura-2 loaded tracheal smooth muscle.
ISO  reduces  contraction  more  than  Ca2+ concentration.   This  phenomenon  was
mimicked by forskolin and db-cAMP.  In contrast,  an inhibition in tension by SKF-
96365,  a  non-selective  Ca2+ channel  inhibitor,  was  associated  with  that  in  F340/F380,
different from ISO.  In the presence of Rp-cAMP, a membrane-permeable inhibitor of
protein kinase A (PKA), ISO caused an equivalent relaxation with a less reduction in
F340/F380.  The effects of ISO were not affected in the presence of Y-27632, an inhibitor
of Rho-kinase, and bisindolylmaleimide, an inhibitor of protein kinase C.  Even removal
of Ca2+ from the extracellular surface, the effects of ISO was not affected.  ISO also
inhibits high K+-induced contraction without lowering F340/F380.  However, response to
ISO was completely diminished in the presence of calyculin A, an inhibitor of myosin
phosphatase.  In conclusion, β-adrenergic action antagonizes Ca2+ sensitization mediated
by impairment of myosin phosphatase activity.  Moreover, cAMP independent process,
G protein direct action, is more potent in inhibiting this Ca2+ sensitization than PKA.
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Introduction
β-adrenergic  receptor  agonists  (β-agonists)  are  well  known  to  suppress
contraction  in  airway smooth  muscle  induced  by various  contractile  agents  such  as
acetylcholine,  histamine,  and  eicosanoids,  and  widely used  clinically  to  relief  acute
asthma attacks.   These contractile agents transiently bring about an augmentation in
intracellular Ca2+ concentration ([Ca2+]i), followed by a reduction in [Ca2+]i level that is
higher than the control level (1, 2).  This transient increase in [Ca2+]i in the initial phase
is due to Ca2+ release from the sarcoplasmic reticulum, whereas the subsequent higher
[Ca2+]i level than the control is due to Ca2+ influx from the extracellular side.  Although
[Ca2+]i level  reduces  in  the  presence  of  these  agonists,  the  tonic  contraction  is  still
sustained in airway smooth muscle (2, 3, 4).   Hence, the tonic contraction in airway
smooth muscle is mediated by not only Ca2+ influx but also Ca2+ sensitization.  It has
been  recently  revealed  that  Rho-kinase,  which  is  a  target  enzyme of  Rho  (a  small
monomeric G protein), inhibits the regulatory subunit of myosin phosphatase (5, 6, 7,
8), and that the Rho/Rho-kinase processes may result in an augmentation in sensitivity
to intracellular Ca2+ by which agonist-induced contraction is regulated in airway smooth
muscle (9, 10, 11).
Effects  of  β-agonists  on  relationship  between  isometric  contractions  and
[Ca2+]i have been mainly studied in mobilization of [Ca2+]i.  β-agonists and other cAMP-
related agents cause membrane hyperpolarization via a reduction in Ca2+ influx (12, 13,
14) and an augmentation in Ca2+-activated K+ channel activity (15, 16, 17, 18), leading
to a reduction in [Ca2+]i.  Ca2+ mobilization by these processes affects tone of airway
smooth  muscle  mediated  by  Ca2+/calmodulin-  dependent  myosin  light  chain  kinase
(MLCK) (19, 20).  On the other hand, it is currently proposed that theophylline and
cAMP may reduce Ca2+ sensitization to antagonize contraction by contractile agents,
because  cAMP-dependent  protein  kinase  (PKA)  causes  an  augmentation  in  myosin
phosphate  via  Rho/Rho-kinase  and  other  mechanisms  (21,  22).   Hence,  both  Ca2+
mobilization and Ca2+ sensitization may play an important functional role in the effect of
cAMP-related  agents  on  smooth  muscle.   However,  little  is  still  known  about  a
reduction  in  Ca2+ sensitization  elicited  by  β-agonists  in  detail,  because  cAMP-
independent pathways are involved in the β-adrenergic action (23, 24). 
This study was designed to determine involvement of Ca2+ sensitization in the
functional antagonism between β-agonists and contractile agents.  We examined causal
relationship between Ca2+ mobilization and Ca2+ sensitization in the inhibitory effects of
β-agonists on contraction induced by a muscarinic receptor agonist using intact tracheal
smooth muscle.  Moreover, we examined mechanisms underlying suppression of Ca2+
sensitization in β-adrenergic action. 
Materials and Methods
Tissue Preparation and Solution 
Male  guinea  pigs  (300-350  g)  were  killed  by  injection  of  overdose  of
anesthetics  (150 mg/kg pentobarbital,  i.p.)  and tracheas  were excised.   The  tracheal
rings  were  opened by  cutting  longitudinally  at  the  cartilaginous  region,  and  the
epithelium was dissected out.  The normal bathing solution was composed of (in mM):
NaCl 137, KHCO3 5.9, CaCl2 2.4, MgCl2 1.2, and glucose 11.8, bubbled with a mixture
of 99% O2 and 1% CO2 (pH 7.4).  For the high K+ solution (40 mM), NaCl was replaced
with an equi-molar concentration of KCl.  For the nominally free Ca2+ solution, CaCl2
was replaced with an equi-molar concentration of NaCl.  The bathing solution was filled
in the organ bath at a constant flow of 3 ml/min.  The temperature of the organ bath was
maintained at 37 °C.
Isometric Tension Recording and Measurement of Fura-2 Fluorescence
The methods are essentially similar to those described previously (11,  25).
Muscle strips containing four cartilaginous rings, one for isometric tension recording
and three for [Ca2+]i measurements, were prepared.  Muscle strips were treated with 10
µM acetoxymethyl ester of fura-2 for 4 h at room temperature (22-24 °C).  The non-
cytotoxic detergent, pluronic F-127 (0.01% wt/vol), was added to increase the solubility
of fura-2.  After the loading, the chamber was filled with the normal solution at 37 °C for
50 min to wash out the extracellular fura-2 before the measurements.  Isometric tension
and the fura-2 fluorescence of  muscle  strips  were  measured  simultaneously,  using a
displacement  transducer  and  a  spectrofluorometer  (CAF-110;  Japan Spectroscopic,
Tokyo, Japan).  The intensities of fluorescence due to excitation at 340 (F340) and 380
(F380) nm were measured after background subtraction.  The absolute amount of [Ca2+]i
was not calculated because the dissociation constant of fura-2 for Ca2+ in smooth muscle
cytoplasm is known to be different from that obtained in vitro (26).  Therefore, the ratio
of F340 to F380 (F340/F380) was used as a relative indicator of [Ca2+]i.  MCh 1 µM was
applied for 5 minutes at every 15 minutes to establish stable response to MCh, and the
experiment started.  Muscle tension and F340/F380 in the resting state were taken as 0%,
and the values of percent contraction and F340/F380 were expressed by taking 1 µM MCh-
induced contraction and 40 mM K+ induced contraction at each experimental condition
as 100%.  The resting tone was abolished by addition to 2 µM indomethacin throughout
the experiments.  
Experimental Protocol
To examine relationship between relaxation and [Ca2+]i in β-adrenergic action,
isoproterenol (ISO) was cumulatively applied to the fura-2 loaded tissues pre contracted
by 1  µM MCh.  To examine relationship between relaxation and [Ca2+]i in  the post
receptor signal transduction processes, forskolin, a direct activator of adenylate cyclase,
and  dibtilyl  cyclic  AMP  (db-cAMP),  non  hydrolysable  cAMP,  were  cumulatively
applied in the same way.  To examine the inhibitory effects of Ca2+ mobilization on
MCh-induced contraction, SKF-96365, an inhibiter of non-selective Ca2+ channels, and
verapamil,  voltage-dependent Ca2+ channel blockers,  were cumulatively applied in the
same way.  To examine the inhibitory effects  of Ca2+ sensitization on MCh-induced
contraction, Y-27632, an inhibiter of Rho kinase, was cumulatively applied in the same
way.  To determine the mechanisms underlying Ca2+ sensitization by  β-agonists,  the
inhibitory action of β-agonists was examined in the presence of Rp-cAMP, a membrane-
permeable inhibitor of PKA, bisindolylmaleimide (BIM), an inhibitor of protein kinase
C, and calyculin A, an inhibitor of myosin phosphatase.  To determine the involvement
of  Ca2+ mobilization,  the  inhibitory  action  of  β-agonists  was  examined  under  the
condition of nominally Ca2+ free and 40 mM K+ solution in the extracellular surface.
Materials 
Isoproterenol, MCh, indomethacin, forskolin, db-cAMP, SKF-96365, BIM, calyculin A,
and pluronic F-127 were obtained from Sigma Chemical (St. Louis, MO).  Y-27632 was
a  gift from  Welfide  Co.  Ltd.  (Osaka,  Japan).   Rp-adenosine-3',5'-cyclic
monophosphorothioate (Rp-cAMP) was obtained from BIOLOG Life Science Institute
(Bremen, Germany).  Fura-2 was from Dojin Laboratories (Kumamoto, Japan).  Fura-2
was dissolved in dimethyl sulfoxide (DMSO), and the final DMSO concentration did not
exceed 0.5%. Neither drug affected the fura-2 fluorescence ratio at the concentrations
used. 
Statistical Analysis 
All data were expressed as means ± standard deviation.  The statistical significance in
all data was assessed with repeated measures ANOVA with the Bonferroni post hoc test
using all  concentration.    Probability below 0.05 (P < 0.05) was considered to  be a
significant difference. 
Results
The inhibitory effects of β-agonists on tension and [Ca2+]i induced by MCh
When  ISO  (0.003-1  µM) was  cumulatively  applied  to  the  fura-2-loaded
tissues,  ISO  inhibited  both  contraction  and  [Ca2+]i induced  by  1  µM  MCh  in  a
concentration-dependent manner.   These  inhibitory  actions  are  more  potent  in
contraction than in [Ca2+]i (Fig. 1A).  The values of percent contraction for 1 µM MCh
with ISO inhibition were 0 ± 0%, whereas the values of percent F340/F380 under this
condition were 27.9 ± 6.6% (n = 8).  The concentration-inhibition curve for ISO in
tension is markedly dissociated from the curve in [Ca2+]i (P  < 0.01).  The values of
percent contraction for 1  µM MCh with 0.003, 0.01, 0.03, 0.1, and 0.3  µM ISO were
95.3 ± 4.8, 69.7 ± 12.3, 22.1 ± 10.7, 6.0 ± 4.7, and 0.0 ± 0.0%, respectively (n = 8; Fig.
1B).  In contrast, those values of the percent F340/F380 for 1  µM MCh with equi-molar
ISO were 87.7 ± 2.8, 77.2 ± 8.6, 54.1 ± 4.5, 42.7 ± 11.6, and 33.1 ± 9.8%, respectively
(n = 8; Fig. 1B).  At each concentration of ISO, a reduction in tension was greater than
that in [Ca2+]i, and this discrepancy became more remarkable as concentration of ISO
was increased.
The  inhibitory  effects  of  adenylate  cyclase  stimulator  on  tension  and [Ca2+]i
induced by MCh
Application  of  forskolin  (0.1-10  µM)  inhibited  both  tension  and  [Ca2+]i
induced by 1 µM MCh (Fig. 2A).  However, although 10 µM forskolin caused complete
inhibition,  [Ca2+]i was much higher than that  in the basal  level,  similar  to ISO.  As
shown in Fig. 2B, there was also a marked dissociation in the concentration- inhibition
curves for forskolin in between tension and [Ca2+]i (P < 0.05). The values of percent
contraction for 1  µM MCh with 0.1, 0.3, 1, 3, and 10  µM forskolin inhibition were
93.9 ± 3.5,  81.4 ± 6.8,  48.7 ± 12.7,  11.7 ± 8.5,  and  0.0 ± 0.0%,  respectively  (n  =  6),
whereas the values of the percent F340/F380 for 1  µM MCh with equi-molar forskolin
inhibition  were  89.1 ± 1.3,  73.6 ± 3.5,  57.8 ± 3.1,  33.4 ± 9.4,  and  16.4 ± 5.6%,
respectively (n = 6; Fig. 2B).  At each concentration of forskolin, a reduction in tension
was  higher  than  that  in  [Ca2+]i,  and  this  discrepancy  became  more  remarkable  as
concentration of forskolin was increased, similar to ISO.
The inhibitory effects of cAMP on tension and [Ca2+]i induced by MCh
When 0.1-3  mM db-cAMP was  cumulatively applied  to  the  fura-2 loaded
tissues, db-cAMP caused a concentration-dependent inhibition in contraction and [Ca2+]i
by 1  µM MCh (Fig.  2C).   3  mM db-cAMP caused  roughly complete  inhibition  in
contraction, whereas [Ca2+]i by an equi-molar of this agent also did not return to the
basal  level.   The concentration-inhibition  curve  for  db-cAMP  in  contraction  was
markedly dissociated from that curve in [Ca2+]i, similar to ISO and forskolin (Fig. 2D; P
< 0.01).  The values of percent contraction for 1  µM MCh with 0.1-3 mM db-cAMP
inhibition were 100.0 ± 0.0, 86.3 ± 5.7, 35.4 ± 8.5, and 10.9 ± 7.1%, respectively (n =
6).  In contrast, the values of the percent F340/F380 for 1 µM MCh with equi-molar of this
agent were 91.4 ± 5.4, 77.9 ± 5.5, 48.2 ± 8.4, and 33.1 ± 6.3%, respectively (n = 6, Fig.
2D).  At each concentration of db-cAMP, a reduction in tension was higher than that in
[Ca2+]i,  and this came more remarkable as concentration of db-cAMP was increased,
similar to ISO and forskolin.
The inhibitory effects of non-selective Ca2+ channels blocker on tension and [Ca2+]i
induced by MCh
A cumulative  application  of  SKF-96365  (1-100  µM)  to  the  fura-2  loaded
tissues pre-contracted by 1 µM MCh resulted in an inhibition in tension and [Ca2+]i in a
concentration-dependent manner (Fig. 3A).  When 30  µM SKF-96365 caused roughly
complete inhibition, [Ca2+]i by equi-molar of this agent was close to that in the basal
level, different from ISO, forskolin, and db-cAMP.  The concentration-inhibition curve
for SKF-96365 in contraction was not dissociated from that curve in [Ca2+]i (Fig. 3B).
The value of percent contraction for 1  µM MCh with 1, 3, 10, 30, and 100 µM SKF-
96365 inhibition were 100.0 ± 0.0, 98.5 ± 2.2, 75.9 ± 10.4, 26.3 ± 22.8, and 0.0 ± 0.0%,
respectively (n = 6).  Those values of the percent F340/F380 for 1  µM MCh with equi-
molar of this agent were 96.6 ± 4.9, 89.9 ± 4.7, 60.3 ± 6.1, 7.1 ± 10.0, and 0.0 ± 0.0%,
respectively (n = 6; Fig. 3B).  There was not a significant difference between curves of
this agent.
The inhibitory effects of Rho on tension and [Ca2+]i induced by MCh
When Y-27632 was  cumulatively applied to  the fura-2  loaded tissues pre-
contracted  by  1  µM  MCh,  Y-27632  caused  an  inhibition  in  tension  by  MCh  in
concentration-dependent  manner.  However,  this  agent  modestly  inhibited  [Ca2+]i
induced  by  MCh  (Fig.  3C).   The concentration-inhibition  curve  for  Y-27632  in
contraction was markedly dissociated  from that  in  [Ca2+]i (Fig.  3D).   The values  of
percent contraction for MCh 1µM with 3, 10, 30, and 100 µM Y-27632 inhibition were
93.1 ± 2.7, 83.0 ± 9.4, 70.6 ± 13.9, and 51.9 ± 18.9%, respectively (n = 6).  In contrast,
the values of the percent F340/F380 for 1  µM MCh with equi-molars of this agent were
100.0 ± 0.0, ±, 99.5 ± 1.2, 93.5 ± 5.0, and 85.8 ± 7.4%, respectively (n = 6, Fig. 3D).  At
each concentration of Y-27632, a reduction in tension was much greater than that in
[Ca2+]i, and this discrepancy became more remarkable as concentrations of this agent
were increased.  
Relationships between tension and [Ca2+]i in the inhibitory effects of cAMP-related
agents on MCh-induced contraction
Fig.  4  shows the  relationship  between the  Ca2+ mobilization  and the  Ca2+
sensitization by tension-[Ca2+]i curves.  In Fig. 4 the line (a) means that a reduction in
tension is consistent with that in [Ca2+]i concerning relaxant effects of an agent.  As
shown in Fig. 4A, tension-[Ca2+]i curve for MCh with SKF-96365 (1-100 µM) was very
close to the line (a), but this curve was upper side than the line (a).  The curve for MCh
with verapamil (0.1-3  µM) was upper side than SKF-96365.  On the other hand, the
curve for MCh with ISO (0.003-1 µM) was lower side than the line (a).  The curve for
MCh with Y-27632 (3-100  µM) was lower side than ISO.  As shown in Fig. 4B, the
curves for MCh with forskolin  (0.01-10  µM), and db-cAMP (1-300 mM) were also
lower side than the line (a), and these curves were significantly different from those for
MCh with SKF-96365 and Y-27632.  The curve for MCh with ISO was lower side than
those for MCh with forskolin, and db-cAMP. 
The inhibitory effects of β-agonists independent of Ca2+ influx
When 1 µM ISO was applied to the tissues pre contracted with 1 µM MCh in
the presence of the normal bathing solution (2.4 mM Ca2+), ISO inhibited MCh-induced
contraction with a reduction in [Ca2+]i (Fig. 5A).  The values of percent contraction and
percent F340/F380 were 2.2 ± 3.1 and 18.5 ± 14.2% (n = 6), respectively (Fig. 5D).  
The inhibitory effects  of  ISO on MCh-induced contraction were  examined
under the condition of a reduction in Ca2+ in the extracellular surface.  After the tissues
were contracted by 1 µM MCh in the normal bathing solution, the extracellular side was
changed to  the nominally Ca2+ free solution.   Under this  experimental condition,  an
equi-molar MCh generated force with an elevation of F340/F380 (Fig. 5B).  The values of
percent contraction and percent F340/F380 for MCh were 51.9 ± 16.0, and 49.3 ± 11.2% of
control condition (n = 6), respectively.  When 1 µM ISO was applied to the tissues pre
contracted by 1 µM MCh in the presence of the nominally Ca2+ free solution, ISO also
antagonized MCh-induced contraction with a reduction in  F340/F380 (Fig. 5B).   Those
values percent contraction and percent F340/F380 for MCh with ISO were 3.7 ± 2.5, and
36.4 ± 17.1% (n = 6), respectively (Fig. 5D).  Inhibiting contraction by equi- molar ISO
was identical, however reducing F340/F380 by equi-molar ISO was significantly lowered.  
Next, 1 µM ISO was applied to the tissues pre contracted by 40 mM K+.  As
shown in Fig 5C, ISO caused an inhibition in 40 mM K+-induced contraction with a
modest reduction in [Ca2+]i, similar to the inhibitory effects of Y-27632 against MCh
(ref. Fig 3).  The values of percent contraction and percent F340/F380 for 40 mM K+ with
ISO were 32.3, ± 8.3 and 95.2, ± 2.0% (n = 6; Fig. 5D).  
Involvement  of  PKA,  PKC,  and  Rho-kinase  in  Ca2+ mobilization  and  Ca2+
sensitization induced by β-agonists 
Rp-cAMP 100 µM caused a modest inhibition in tension and [Ca2+]i induced
by MCh (Fig. 6A).  When 1 µM ISO was applied to the tissues precontracted by 1 µM
MCh and 100 µM Rp-cAMP, ISO antagonized MCh-induced contraction similar to the
control  condition.   Even though ISO similarly inhibited MCh-induced contraction,  a
reduction in  F340/F380 by ISO was significantly lowered (Fig. 6A; ref. Fig. 5A).  In the
presence of 100  µM Rp-cAMP the value of percent contraction and percent F340/F380
were 5.0 ± 3.7, and 56.2 ± 12.5% (n = 6), respectively (P < 0.05; Fig. 6A and 6D).  
BIM 10 µM caused a modest inhibition of contraction and [Ca2+]i induced by
1 µM MCh (Fig. 6B).  When 1  µM ISO was applied to the tissues in the presence of
MCh and BIM, ISO suppressed both contraction and F340/F380 induced by MCh, similar
to the control condition (Fig. 6B; ref. Fig. 5A).  Under the experimental condition, the
values of percent contraction and percent F340/F380 for MCh with ISO were 4.0 ± 2.8, and
20.5 ± 9.2%, respectively (n = 6; Fig. 6B and 6D).
In the same way, when 1 µM ISO was applied to the tissues in the presence of
1  µM MCh and 10  µM Y-27632, ISO also suppressed both contraction and F340/F380
induced by MCh similar to the control condition (Fig. 6C; ref. Fig. 5A).  The values of
percent contraction and percent F340/F380 for MCh with Y-27632 were 70.2 ± 16.3 and
93.5 ± 5.6%, respectively.  In the presence of Y-27632, the values of percent contraction
and percent F340/F380 for MCh with ISO were 2.9 ± 1.5 and 16.8 ± 8.4%, respectively (n
= 6; Fig. 6C and 6D).  
The inhibitory effects of β-agonists on myosin phosphatase activity
Application of 300 nM calyculin A caused contraction without any changing
in F340/F380 (Fig. 7A).  Calyculin A-induced contraction was slowly generated without
phasic component, and the maximal response was observed 15 ~ 20 min after exposure.
The value  of  percent  contraction  for  this  agent  was  59.0  ± 18.2% of  1  µM MCh-
induced contraction (n = 6;  Fig.  7B).   When 1  µM ISO was applied to tissues  pre
constricted  by calyculin  A,  ISO did  not  inhibit  it  (Fig.  7A).   The  value  of  percent
contraction for MCh with ISO was 57.9 ± 21.2% (n = 6; Fig. 7B).
Discussion
Our  results  have  demonstrated  for  the  first  time  that  β-agonists  cause  an
inhibition  of  MCh-induced contraction via  not  only Ca2+ mobilization but  also Ca2+
sensitization, using intact tracheal smooth muscle.  Force generation in smooth muscle
is mediated by an increase in both concentration of intracellular Ca2+ and sensitivity to
intracellular Ca2+.  These two processes are affected when β-agonists and other cAMP-
related  agents  inhibit  MCh-induced  contraction.   However,  regulation  of  Ca2+
sensitization  plays  a  more  important  role  in  β-adrenergic  action  than  other  cAMP-
related agents in airway smooth muscle.  
As shown in Figs. 1 and 2, in the inhibitory action of ISO, forskolin, and db-
cAMP against MCh-induced contraction, a reduction in tension was not associated with
that in [Ca2+]i.  The concentration-percent contraction curves for MCh with  β-agonists
and other cAMP-related agents were significantly lower than the concentration-percent
F340/F380 curves.  This phenomenon was mimicked using other contractile agents such as
histamine  and  leukotriene  D4 (Data  not  shown).   These  results  demonstrate  that  a
reduction in not only Ca2+ influx but also Ca2+ sensitization is involved in the functional
antagonism of β-agonists and other cAMP-related agents.  The inhibitory action of ISO,
forskolin, and db-cAMP on tension and [Ca2+]i was different from that of SKF 96365
(Fig. 3), indicating that  β-agonists and other cAMP-related agents do not behave as a
non-selective  Ca2+ channel  blocker.   This  observation  also  supports  the  idea  that  a
reduction  in  Ca2+ sensitization  is  involved  in  cAMP-dependent  relaxation  in  airway
smooth muscle.  
As shown in Fig. 4A, the tension-F340/F380 curve for SKF-96365 and verapamil
existed between line (a) and (c).  This area contains that a more reduction in [Ca2+]i
needs to obtain an equivalent relaxation by an agent.  Hence, these results indicate that a
reduction  in  [Ca2+]i is  insufficient  to  antagonize  toward  contraction  induced  by
contractile  agents,  and  that  other  mechanisms  need  to  enhance  their  functional
antagonism.  In contrast, the tension-F340/F380 curve for Y-27632 was close to the line (b)
(Figs. 3 and 4A).  The curve for wortmannin, an inhibitor of MLCK, was also close to
the line (b) (Data not shown).  This result indicates that the relationship between tension
and  [Ca2+]i is  considered  to  be  drawn  along  the  line  (b)  when  agonist-induced
contraction  is  antagonized  by  sensitivity  to  intracellular  Ca2+.   The  tension-F340/F380
curves for ISO, forskolin, and db-cAMP existed between the line (a) and (b) (Fig. 4).
This area contains that a more inhibition in contraction causes at an equivalent level of
[Ca2+]i.  This phenomenon was also mimicked by other  β-agonists such as procaterol
and salmeterol (Data not shown).  These results also support the idea that cAMP-related
agents containing β-agonists cause relaxation of airway smooth muscle mediated by not
only Ca2+ mobilization but also Ca2+ sensitization, and that these agents do not behave as
non-selective and voltage-dependent Ca2+ channel blockers.  
When the nominally free Ca2+ solution was applied to the extracellular side,
driving force in Ca2+ influx was lowered.  However, the inhibitory effect of ISO against
tension was not affected even though Ca2+ influx by this agonist was decreased (Fig. 5B
and 5D).  This observation suggests that β-agonists antagonize contraction induced by
the  contractile  agents,  such  as  MCh,  histamine  and  leukotriene,  in  airway  smooth
muscle, independent of a reduction in Ca2+ influx.  Application of ISO also resulted in
an inhibition in 40 mM K+-induced contraction with a modest reduction in [Ca2+]i (Fig.
5C and 5D).   Although the mechanisms underlying high K+-induced contraction are
different  from  mechanisms  underlying  contractions  by  these  contractile  agents,  this
result explains again that reduction of sensitivity to Ca2+ by β-agonists is involved in the
functional antagonism induced by β-agonists.
The tension-F340/F380 curves for MCh with ISO inhibition was closer to the line
(b)  than  that  for  MCh  with  forskolin,  and  db-cAMP  (Fig.  4B).   These  results
demonstrate that an inhibition in sensitivity to Ca2+ is more potent in  β-agonists than
cAMP-related  agents  bypassing  β-adrenergic  receptors.   β-adrenergic  receptors  are
coupled to the dual pathway of intracellular signal transduction, i.e. 1) cAMP-dependent
PKA phosphorylation (15, 27, 28), 2) cAMP-independent, direct activation by G protein
(Gs) (29, 30).  Gs is more potent in activation of KCa than cAMP/PKA (23), and KCa
channel  regulation  by  Gs may  be  related  to  the  functional  antagonism  between  β-
adrenergic receptors and muscarinic receptors (31).  As shown in Fig. 6A, a reduction in
F340/F380 by ISO was markedly lowered to  obtain an equivalent  relaxation under the
condition that PKA was inactivated by Rp-cAMP.  Activation of Gs is more potent in
inhibiting Ca2+ sensitization than that of cAMP/PKA.  Reduced responsiveness to  β-
agonists is mediated by an augmentation in Ca2+ sensitization and Ca2+ mobilization via
Gs dysfunction (14, 25, 32, 33).  In tracheal smooth muscle  β-adrenergic action is not
affected after excessive exposure to forskolin, db-cAMP, and theophylline that elevate
concentration on intracellular cAMP independent of receptor/Gs processes (14, 32, 33).
Since full agonist action is closely related to Gs-mediated processes, response to full
agonists is not so affected even though β-adrenergic receptor function is impaired (34,
35,  36).   On the other hand,  since partial  agonist  action is  closely related to  PKA-
mediated  processes,  response  to  partial  agonists  are  markedly  attenuated  under  the
condition  of  β-adrenergic  desensitization  (34,  35,  36).   Hence,  Ca2+ sensitization
regulated by Gs plays a functional key role in the β-adrenergic action on airway smooth
muscle.
Recently, it has been reported that theophylline and cAMP inhibit contraction
of  tracheal  smooth muscle mediated by reduction of  Rho-induced Ca2+ sensitization
(21).  On the other hand, cAMP suppresses PKC-mediated Ca2+ sensitization in airway
smooth  muscle  (37).   In  cAMP/PKA processes  mechanisms  of  antagonism to  Ca2+
sensitization is still controversial.  Since Ca2+ sensitization is generally considered to be
mediated by Rho-kinase and PKC, we examined whether these pathways are involved in
the Ca2+ sensitization antagonized by β-agonists in this study.  As shown in Figs. 6B,
6C,  and  6D,  in  the  presence  of  Y-27632  and  BIM,  ISO  inhibited  MCh-induced
contraction in the same way.  Even through Rho-kinase and PKC are inactivated, the
inhibitory action of β-agonists are not affected.  Although these two kinases result in an
augmentation in sensitivity to Ca2+, other processes are involved in this phenomenon in
airway smooth muscle.  Both Ca2+ influx passing through non-selective Ca2+ channel
and Ca2+ sensitization mediated by MLCK processes play an important role in this force
generation  (38,  39).   As  shown in  this  study, relaxant  agents  may affect  both  Ca2+
mobilization  and  Ca2+ sensitization  induced  by  contractile  agents.   However,  when
myosin phosphatase was inactivated in the presence of calyculin A, ISO completely
diminished  the  inhibitory  action  against  MCh-induced  contraction  (Fig  7).   Hence,
myosin phosphatase is considered to be fundamentally affected protein in the functional
antagonist between β-agonists and contractile agents via Ca2+ sensitization.  Recently, it
has  been  revealed  that  ISO  increases  myosin  phosphatase  activity  in  a  time-  and
concentration-dependent  manner  (40).   This  report  supports  the idea  that  β-agonists
bring about a loss of sensitivity to Ca2+ via activation of myosin phosphatase described
above.  However, ISO did not cause an increase in active form of Rho (GTP-Rho), and
did  not  phosphorylate  myosin  phosphatase  targeting  subunit  (data  not  shown),
suggesting that reduced Ca2+ sensitization by  β-agonists is not mediated by Rho/Rho-
kinase  processes.   Further  studies  are  needed  to  clarify  the  mechanism  underlying
myosin phosphatase-induced Ca2+ sensitization.
In conclusions, Ca2+ sensitization regulated by myosin phosphatase plays an
important  functional  role  in  β-adrenergic action on airway smooth  muscle.   cAMP-
independent processes (direct action by Gs)  is  more potent in  this  phenomenon than
cAMP-dependent  processes  (phosphorylation  by  PKA).   Our  results  may  provide
evidence that this Gs/myosin phosphatase stimulatory linkage is a molecular target for
acute asthma management.
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Legends
Figure 1. A reduction in sensitivity to intracellular Ca2+ mediated by a β-agonist.  (A) A
typical  example  of simultaneous  record  of  tension (upper  trace)  and F340/F380 (lower
trace) in the inhibitory effects of ISO (0.003 – 1 µM) on 1 µM MCh.  (B) Concentration-
inhibition curves for ISO on tension (open circles) and F340/F380 (closed circles) induced
by 1 µM MCh.  Tension and F340/F380 in the resting state were taken as 0%, and those in
1  µM  MCh-stimulated  state  were  taken  as  100%.   The  abscissa  expresses  molar
concentration on a log scale.
Figure 2.  A reduction in sensitivity to intracellular Ca2+ mediated by forskolin and db-
cAMP.   (A) A typical  example  of  simultaneous record of  tension (upper  trace)  and
F340/F380 (lower trace) in the inhibitory effects of forskolin (0.1 – 10 µM) on 1 µM MCh.
(B) Concentration-inhibition curves for forskolin on tension (open circles) and F340/F380
(closed circles)  induced by MCh.  (C) A typical  example of simultaneous record of
tension (upper trace) and F340/F380 (lower trace) in the inhibitory effects of db-AMP (0.1
– 3 µM) on 1 µM MCh.  (D) Concentration-inhibition curves for db-cAMP on tension
(open circles)  and F340/F380  (closed circles)  induced by MCh.  The values  of percent
contraction and F340/F380 for MCh with forskolin and db-cAMP were expressed as same
way as that shown in Figure 1B.  The abscissa expresses molar concentration on a log
scale.
Figure 3.  A reduction in sensitivity to intracellular Ca2+ mediated by SKF-96365 and Y-
27632.   (A) A typical  example  of  simultaneous record of  tension (upper  trace)  and
F340/F380 (lower trace) in the inhibitory effects of SKF-96365 (10 – 100 µM) on 1 µM
MCh.  (B) Concentration-inhibition curves for SKF-96365 on tension (open circles) and
F340/F380 (closed circles) induced by MCh.  (C) A typical example of simultaneous record
of tension (upper trace) and F340/F380 (lower trace) in the inhibitory effects of Y-27632 (3
– 100 µM) on 1 µM MCh.  (D) Concentration-inhibition curves for Y-27632 on tension
(open circles)  and F340/F380  (closed circles)  induced by MCh.  The values  of percent
contraction and F340/F380 for MCh with SKF-96365 and Y-27632 were expressed as same
way as that shown in Figure 1B.  The abscissa expresses molar concentration on a log
scale.  
Figure 4.  Role of Ca2+ mobilization and Ca2+ sensitization in the functional antagonism
between MCh and various relaxant agents.  (A) Tension- F340/F380 curves for MCh with
SKF-96365,  verapamil,  Y-27632,  and  ISO.   (B)  Those  curves  for  MCh  with  ISO,
forskolin, and db-cAMP (cAMP related agents).  The values of percent contraction and
F340/F380 for MCh with these relaxant agents were expressed as same way as that shown
in Figure 1B.  See the contents concerning the line a, b, and c.   
Figure  5.   β-adrenergic  relaxation  without  Ca2+ influx.   (A)  A typical  example  of
simultaneous record of tension (upper trace) and F340/F380 (lower trace) in the inhibitory
effect of 1 µM ISO on an equi-molar MCh-induced contraction.  (B) A typical example
of  simultaneous  record  of  tension  (upper  trace)  and  F340/F380 (lower  trace)  in  the
inhibitory effect of an equi-molar ISO on an equi-molar MCh-induced contraction in the
presence of 0 Ca2+ (nominally free Ca2+) at the extracellular side.  (C) A representative of
simultaneous record of tension (upper trace) and F340/F380 (lower trace) in the inhibitory
effect of equi-molar ISO on high K+ (40 mM K+)-induced contraction.  (D) The values
of percent contraction (open column) and percent F340/F380 (closed column) for MCh and
40 mM K+ with ISO under the experimental condition shown in Figures 7A-C.  Tension
and F340/F380 in the resting state were taken as 0%, and those in 1 µM MCh- and 40 mM
K+-stimulated state at each experimental condition were taken as 100%.  
Figure 6.   Mechanisms  underlying reduced Ca2+ sensitization by  β-agonists.   (A) A
typical  example  of simultaneous  record  of  tension (upper  trace)  and F340/F380 (lower
trace) in the inhibitory effects of 1  µM ISO on 1 µM MCh-induced contraction in the
presence of 100 µM Rp-cAMP.  (B) A typical example of simultaneous record of tension
(upper trace) and F340/F380 (lower trace) in the inhibitory effects of an equi-molar ISO on
an  equi-molar  MCh-induced  contraction  in  the  presence  of  1  µM  BIM.   C)  A
representative of simultaneous record of tension (upper trace) and F340/F380 (lower trace)
in the inhibitory effect of an equi-molar ISO on an equi-molar MCh-induced contraction
in  the  presence  of  10  µM  Y-27632.   (D)  The  values  of  percent  contraction  (open
column) and percent F340/F380 (closed column) for MCh with ISO under the experimental
condition shown in Figures 6A-C.  Those values were expressed in the same way as
Figure 5D.  Those values in control are identical to those values shown in the inhibitory
effects of 1 µM ISO on 1 µM MCh-induced contraction in the presence of the normal
bathing solution (ref. Figures 5A, and 5D). 
Figure 7.  Involvement of myosin phosphatase inhibition in the β-adrenergic action.  (A)
A typical example of simultaneous record of tension (upper trace) and F340/F380 (lower
trace) in the inhibitory effects of 1 µM ISO on 300 nM calyculin A-induced contraction.
(B) The values of percent contraction for 1 µM MCh and 300 nM calyculin A with 1 µM
ISO inhibition.  The value of percent contraction for MCh with ISO is identical to that
shown in Fig.  5D.  Those values were expressed taking response to 1  µM MCh as
100%.
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